With strong Phase 2 results and an eventual CE mark, it will really legitimize Biomoda and their technology. They will be off the OTC by year end, I would imagine. This is all under the assumption of good results.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.